Open access
Sep 2026
Combined Taraxacum mongolicum and Astragalus polysaccharides attenuate CCl4-induced hepatic fibrosis through modulation of the TLR4/MyD88/NF-κB signaling pathway and gut microbiota composition
TMP combined with APS exerts enhanced anti-hepatic fibrosis effects compared with either monotherapy, and is associated with changes in gut microbiota composition, elevated fecal short-chain fatty acid levels, and reduced expression of hepatic TLR4/MyD88/NF-κB pathway-related molecules.
Yin-Jie Ma, Chao-Xing Wang, Xue Chen et al.
· Frontiers in Pharmacology · 0 citations